Anavex Other Current Assets vs Net Receivables Analysis
AVXL Stock | USD 4.50 0.15 3.45% |
Anavex Life financial indicator trend analysis is way more than just evaluating Anavex Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anavex Life Sciences is a good investment. Please check the relationship between Anavex Life Other Current Assets and its Net Receivables accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
Other Current Assets vs Net Receivables
Other Current Assets vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anavex Life Sciences Other Current Assets account and Net Receivables. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Anavex Life's Other Current Assets and Net Receivables is 0.15. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Anavex Life Sciences, assuming nothing else is changed. The correlation between historical values of Anavex Life's Other Current Assets and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Anavex Life Sciences are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Other Current Assets i.e., Anavex Life's Other Current Assets and Net Receivables go up and down completely randomly.
Correlation Coefficient | 0.15 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Net Receivables
Most indicators from Anavex Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anavex Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. At this time, Anavex Life's Selling General Administrative is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 47.1 M this year, although Enterprise Value Over EBITDA will most likely fall to (7.39).
2021 | 2022 | 2023 | 2024 (projected) | Tax Provision | 358.5K | 7K | 8.1K | 7.6K | Interest Income | 947.0K | 6.5M | 7.5M | 7.9M |
Anavex Life fundamental ratios Correlations
Click cells to compare fundamentals
Anavex Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anavex Life fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
Other Current Liab | 3.3M | 5.6M | 5.9M | 7.3M | 8.4M | 8.8M | |
Total Current Liabilities | 7.3M | 10.8M | 10.2M | 12.5M | 14.4M | 15.1M | |
Total Stockholder Equity | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 171.3M | |
Net Debt | (29.2M) | (152.1M) | (149.2M) | (151.0M) | (135.9M) | (129.1M) | |
Retained Earnings | (159.7M) | (197.6M) | (245.6M) | (293.1M) | (263.8M) | (250.6M) | |
Cash | 29.2M | 152.1M | 149.2M | 151.0M | 173.7M | 182.4M | |
Cash And Short Term Investments | 29.2M | 152.1M | 149.2M | 151.0M | 173.7M | 182.4M | |
Common Stock Total Equity | 52.7K | 62.0K | 75.9K | 77.9K | 89.6K | 94.1K | |
Common Stock Shares Outstanding | 58.2M | 69.8M | 76.9M | 79.8M | 91.8M | 96.3M | |
Liabilities And Stockholders Equity | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
Other Stockholder Equity | 186.9M | 348.3M | 388.0M | 434.8M | 500.1M | 525.1M | |
Total Liab | 7.3M | 10.8M | 10.2M | 12.5M | 14.4M | 15.1M | |
Total Current Assets | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
Common Stock | 62.0K | 75.9K | 77.9K | 82K | 94.3K | 99.0K | |
Accounts Payable | 4.0M | 4.7M | 3.8M | 4.3M | 5.0M | 5.2M | |
Other Current Assets | 443.8K | 355.5K | 354.2K | 653K | 751.0K | 495.2K | |
Non Current Liabilities Total | 3.3M | 5.6M | 4.3M | 7.3M | 8.4M | 8.8M | |
Net Receivables | 4.8M | 9.1M | 3.2M | 2.7M | 3.1M | 2.1M | |
Net Tangible Assets | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 171.3M | |
Retained Earnings Total Equity | (133.4M) | (159.7M) | (197.6M) | (245.6M) | (221.0M) | (210.0M) | |
Capital Surpluse | 153.6M | 186.9M | 348.3M | 388.0M | 446.2M | 468.5M | |
Net Invested Capital | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 82.9M | |
Net Working Capital | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 82.9M | |
Capital Stock | 62.0K | 75.9K | 77.9K | 82K | 94.3K | 72.7K |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Anavex Life Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Anavex Stock analysis
When running Anavex Life's price analysis, check to measure Anavex Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anavex Life is operating at the current time. Most of Anavex Life's value examination focuses on studying past and present price action to predict the probability of Anavex Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anavex Life's price. Additionally, you may evaluate how the addition of Anavex Life to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Anavex Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Return On Assets (0.20) | Return On Equity (0.29) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.